24×7 Live News


Indian Drugmaker Marion Biotech Halts Manufacture of Cough Syrup

The Central Drugs Standard Control Organization (CDSCO) is in contact with the national drug regulator of Uzbekistan regarding the matter.

“Immediately on receipt of the information, joint inspection of the NOIDA facility of the manufacturer, Marion Biotech, was carried out by UP Drug Control and CDSCO team and further action as appropriate would be initiated based on the inspection report,” said the Union health ministry on Thursday.

The samples of the cough syrup have been taken from the manufacturing premises and sent to Regional Drugs Testing Laboratory (RDTL), Chandigarh for testing.


Meanwhile, Marion Biotech Pharma company has said that it has sent samples of the said cough syrup for testing and has also halted the production of the product.

Hasan, the Legal Head of Marion Biotech, expressed grief over the deaths on behalf of the company and said that an inquiry in the matter was being conducted by the government.

He added that samples were collected and action would be taken on the basis of the report.

Uzbekistan’s health ministry, on Tuesday, December 27, 2022, said that 18 children suffering from an acute respiratory disease died after taking excessive doses of cough syrup Dok 1 Max, manufactured by Marion Biotech.

Source: IANS

Source link


Your email address will not be published. Required fields are marked *